Home > Blog Tag

Blog Posts by Tag: PAMA

ACLA Launches “Stop Lab Cuts” Campaign Urging Congress to Enact SALSA

The American Clinical Laboratory Association (ACLA) has launched the Stop Lab Cuts advocacy campaign, urging Congress to stop further Clinical Laboratory Fee Schedule (CLFS) cuts under the Protecting Access to Medicare Act (PAMA) through the enactment of the Saving Access to Laboratory Services Act (SALSA).The campaign includes advertising, media outreach, grassroots engagement, stakeholder...

Read


PAMA vs SALSA: 2023 Clinical Lab Fee Schedule Predictions

The Protecting Access to Medicare Act  (PAMA) of 2014 set clinical laboratory fee schedule (CLFS) reimbursement rates on an unsustainable course of multiyear double-digit cuts. Under PAMA, the first set of Medicare CLFS payment rates resulted in cuts of 10% per year in 2018, 2019, and 2020.  As a result of the COVID-19 public health emergency, no reductions were introduced in 2021 or 2022....

Read


Top 5 Blogs Posts of 2021

With ongoing COVID-driven disruptions, 2021 was yet another challenging year for the healthcare industry. XIFIN's Beyond Billing blog kept pace, addressing key issues and hot topics. Here are the top blogs of 2021. 1. UHC Announces Designated Diagnostic Provider Requirements for CoverageWhen UHC announced plans to implement the Designated Diagnostic Provider benefit designs beginning July 1, 2021...

Read


2022 PAMA Reporting Requirements and Reimbursement Cuts Will Impact Hospital and Independent Labs

Update 1/4/2022: Since the publication of this blog, legislation was passed to halt the 2022 reimbursement cuts and reporting requirements. Visit XIFIN’s PAMA Headquarters to view the revised PAMA schedule. After two years of PAMA reporting delays and one year of 0% PAMA related fee cuts, applicable laboratories (including hospital outreach laboratories) need to start preparing for 2022 PAMA...

Read


Lab Week 2021: Reflection and Gratitude

Once again, Lab week is upon us. As the second year celebrating Medical Laboratory Professionals Week (MLPW) in the midst of a global pandemic, it’s worth taking a moment to celebrate all our lab professionals and pathologists. Diagnostics is such a vital piece of the healthcare puzzle, and frontline laboratorians have been visible in unprecedented ways throughout the pandemic, but it is still...

Read


Recapping the NILA Lab Leaders Forum and Mid-Winter Meeting

Last weekend’s NILA conference covered a number of items currently impacting laboratories across the country. Several topics, in particular, saw repeated discussions and, in some cases, vigorous debate from the audience. Here are the hottest topics and key takeaways from the NILA meeting:Prior Authorization’s Pinch This was potentially one of the most intriguing discussions revolved around prior...

Read


Top 5 Industry News Topics of 2019

2019 saw many policy changes and newsworthy events that affected labs and medical billers. Here is a recap of our most-viewed industry news articles of 2019:1. New Codes Effective July 1, 2019 – Proprietary Laboratory Analysis (PLAs)The following new codes may need to be manually added to the HCPCS file by the MACs with an effective date of July 1, 2019. These new codes are also contractor-priced...

Read


Hottest Blog Topics of 2019

In 2019 we discussed many thought-provoking topics and trends regarding laboratories, medical billing, revenue cycle management, and much more. Here is a short recap of the top 5 most-influential blog posts:1. Hidden Landmines in Revenue Cycle Management: Industry Challenges, Patient Engagement, and Denial TrendsMany trends in payor behaviors and reimbursement go unnoticed due to outdated RCM...

Read